Janet Romrell

1.9k total citations
25 papers, 1.4k citations indexed

About

Janet Romrell is a scholar working on Neurology, Cognitive Neuroscience and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Janet Romrell has authored 25 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Neurology, 5 papers in Cognitive Neuroscience and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Janet Romrell's work include Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (14 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Janet Romrell is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (18 papers), Neurological disorders and treatments (14 papers) and Botulinum Toxin and Related Neurological Disorders (3 papers). Janet Romrell collaborates with scholars based in United States, Germany and Canada. Janet Romrell's co-authors include Michael S. Okun, Hubert H. Fernandez, Ramon L. Rodriguez, Charles E. Jacobson, Kelly D. Foote, Samuel S. Wu, Hubert H. Fernandez, Christine M. Sapienza, John C. Rosenbek and Herbert E. Ward and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neurology.

In The Last Decade

Janet Romrell

24 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Janet Romrell United States 15 1.0k 427 257 188 158 25 1.4k
David Maltête France 23 1.4k 1.4× 506 1.2× 49 0.2× 206 1.1× 114 0.7× 78 1.8k
Christopher W. Hess United States 26 1.2k 1.2× 602 1.4× 62 0.2× 130 0.7× 108 0.7× 72 1.7k
Raja Mehanna United States 15 830 0.8× 292 0.7× 62 0.2× 84 0.4× 83 0.5× 43 1.0k
S. S. O'Sullivan Ireland 12 671 0.6× 242 0.6× 39 0.2× 118 0.6× 145 0.9× 19 1.1k
Anne‐Louise Lafontaine Canada 19 826 0.8× 165 0.4× 46 0.2× 156 0.8× 256 1.6× 37 1.3k
Masayoshi Kusumi Japan 23 565 0.5× 196 0.5× 51 0.2× 494 2.6× 236 1.5× 44 1.4k
Guangqing Xu China 18 197 0.2× 249 0.6× 138 0.5× 85 0.5× 174 1.1× 64 1.0k
Leslie Livingston New Zealand 13 1.3k 1.3× 191 0.4× 28 0.1× 427 2.3× 219 1.4× 20 1.7k
Anna Sauerbier United Kingdom 23 1.4k 1.4× 253 0.6× 47 0.2× 115 0.6× 133 0.8× 56 1.6k
Ute Hidding Germany 15 406 0.4× 160 0.4× 132 0.5× 107 0.6× 94 0.6× 34 653

Countries citing papers authored by Janet Romrell

Since Specialization
Citations

This map shows the geographic impact of Janet Romrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Romrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Romrell more than expected).

Fields of papers citing papers by Janet Romrell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Romrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Romrell. The network helps show where Janet Romrell may publish in the future.

Co-authorship network of co-authors of Janet Romrell

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Romrell. A scholar is included among the top collaborators of Janet Romrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Romrell. Janet Romrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hack, Nawaz, Sarah M. Fayad, Erin Hastings, et al.. (2014). An Eight-Year Clinic Experience with Clozapine Use in a Parkinson’s Disease Clinic Setting. PLoS ONE. 9(3). e91545–e91545. 44 indexed citations
2.
Ward, Herbert E., et al.. (2012). Clozapine as a potential treatment for refractory impulsive, compulsive, and punding behaviors in Parkinson’s disease. Neurocase. 19(6). 587–591. 14 indexed citations
3.
Oyama, Genko, Kelly D. Foote, Yunfeng Dai, et al.. (2012). Taking a Better History for Behavioral Issues Pre- and Post-Deep Brain Stimulation: Issues Missed by Standardized Scales. Neuromodulation Technology at the Neural Interface. 16(1). 35–40. 10 indexed citations
4.
Oyama, Genko, Kelly D. Foote, Charles E. Jacobson, et al.. (2012). GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson's disease. Parkinsonism & Related Disorders. 18(7). 814–818. 41 indexed citations
5.
Hwynn, Nelson, Chris J. Hass, Pamela Zeilman, et al.. (2011). Steady or not following thalamic deep brain stimulation for essential tremor. Journal of Neurology. 258(9). 1643–1648. 23 indexed citations
6.
Classen, Sherrilene, Desiree N. Lanford, Michael S. Okun, et al.. (2011). Usefulness of Screening Tools for Predicting Driving Performance in People With Parkinson’s Disease. American Journal of Occupational Therapy. 65(5). 579–588. 41 indexed citations
7.
Classen, Sherrilene, Dennis McCarthy, Orit Shechtman, et al.. (2009). Useful Field of View as a Reliable Screening Measure of Driving Performance in People With Parkinson's Disease: Results of a Pilot Study. Traffic Injury Prevention. 10(6). 593–598. 52 indexed citations
8.
Sass, Jörn Oliver, Janet Romrell, Hubert H. Fernandez, et al.. (2009). Tracing the Origin of L-2-Hydroxyglutaric Aciduria in a Family. International Journal of Neuroscience. 119(11). 2118–2123. 6 indexed citations
9.
10.
Okun, Michael S., Hubert H. Fernandez, Samuel S. Wu, et al.. (2009). Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE Trial. Annals of Neurology. 65(5). 586–595. 411 indexed citations
11.
Fernandez, Hubert H., Michael S. Okun, Ramon L. Rodriguez, et al.. (2009). QUETIAPINE IMPROVES VISUAL HALLUCINATIONS IN PARKINSON DISEASE BUT NOT THROUGH NORMALIZATION OF SLEEP ARCHITECTURE: RESULTS FROM A DOUBLE-BLIND CLINICAL-POLYSOMNOGRAPHY STUDY. International Journal of Neuroscience. 119(12). 2196–2205. 87 indexed citations
12.
Okun, Michael S., Kelly D. Foote, Hubert H. Fernandez, et al.. (2008). Clinical Cases where Lesion Therapy Was Chosen over Deep Brain Stimulation. Stereotactic and Functional Neurosurgery. 86(3). 147–152. 40 indexed citations
13.
Fernandez, Hubert H., Janet Romrell, Martha E. Trieschmann, et al.. (2008). New-Onset Diabetes Mellitus among Parkinsonian Patients Treated with Long-term Quetiapine. 3(1). 2 indexed citations
14.
Foote, Kelly D., Paul J. Seignourel, Hubert H. Fernandez, et al.. (2006). Dual Electrode Thalamic Deep Brain Stimulation For The Treatment Of Posttraumatic And Multiple Sclerosis Tremor. Operative Neurosurgery. 58(suppl_4). ONS–280. 89 indexed citations
15.
Williams, Lindsy N., Paul J. Seignourel, Gregory P. Crucian, et al.. (2006). Laterality, region, and type of motor dysfunction correlate with cognitive impairment in Parkinson's disease. Movement Disorders. 22(1). 141–144. 52 indexed citations
16.
Okun, Michael S., Hubert H. Fernandez, Ramon L. Rodriguez, et al.. (2006). Testosterone Therapy in Men With Parkinson Disease. Archives of Neurology. 63(5). 729–729. 71 indexed citations
17.
Okun, Michael S., Hubert H. Fernandez, Ramon L. Rodriguez, et al.. (2006). Testosterone Therapy in Men With Parkinson Disease. 5 indexed citations
18.
Bruce, Bonnie, Kelly D. Foote, John C. Rosenbek, et al.. (2004). Aphasia and Thalamotomy: Important Issues. Stereotactic and Functional Neurosurgery. 82(4). 186–190. 12 indexed citations
19.
Okun, Michael S., Hubert H. Fernandez, Otto Pedraza, et al.. (2004). Development and initial validation of a screening tool for Parkinson disease surgical candidates. Neurology. 63(1). 161–163. 68 indexed citations
20.
Romrell, Janet, Hubert H. Fernandez, & Michael S. Okun. (2003). Rationale for current therapies in Parkinson’s disease. Expert Opinion on Pharmacotherapy. 4(10). 1747–1761. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Maltête Breakdown of academic impact, for papers by Christopher W. Hess Breakdown of academic impact, for papers by Raja Mehanna Breakdown of academic impact, for papers by S. S. O'Sullivan Breakdown of academic impact, for papers by Anne‐Louise Lafontaine Breakdown of academic impact, for papers by Masayoshi Kusumi Breakdown of academic impact, for papers by Guangqing Xu Breakdown of academic impact, for papers by Leslie Livingston Breakdown of academic impact, for papers by Anna Sauerbier Breakdown of academic impact, for papers by Ute Hidding
Rankless by CCL
2026